Suchergebnisse - "Ciccimarra, Francesco"

PubPharm (8)

1

Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

enthalten in: Vaccine | 2024

von Raethke, M. | van Hunsel, F. | Luxi, N. | +16

2

Exploring the level of agreement among different drug-drug interaction checkers : a comparative study on direct oral anticoagulants

enthalten in: Expert opinion on drug metabolism & toxicology | 2024

von Carollo, M. | Crisafulli, S. | Ciccimarra, F. | +3

3

Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection : A European Multi-Country Study

enthalten in: Vaccines | 2024

von Ciccimarra, F. | Luxi, N. | Bellitto, C. | +16

4

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting : A Nationwide Study from England and Italy

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2023

von Ciccimarra, F. | Luxi, N. | Bellitto, C. | +7

5

Safety of COVID-19 Vaccines Among the Paediatric Population : Analysis of the European Surveillance Systems and Pivotal Clinical Trials

enthalten in: Drug safety | 2023

von Ahmadizar, F. | Luxi, N. | Raethke, M. | +114

6

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy

enthalten in: BioDrugs | 2023

von Ciccimarra, F. | Luxi, N. | Bellitto, C. | +7

7

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy

enthalten in: BioDrugs | 2023

von Ciccimarra, F. | Luxi, N. | Bellitto, C. | +7

8

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy

enthalten in: BioDrugs | 2023

von Ciccimarra, F. | Luxi, N. | Bellitto, C. | +7

1
[1]